Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
51
NCT07044401
A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 14, 2025
Completion: Nov 13, 2025